Loading…
S. 724119th CongressIn committeeLatest action Feb 25, 2025Decoded by AI · checked against the record
Official title: Temporary Extension of Fentanyl-Related Substances Scheduling Act
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
S 724 delays expiration of federal fentanyl analogue Schedule I classification by six months, to September 30, 2025.
45-second read · 4 questions answered below
S 724 extends a temporary federal rule classifying fentanyl-related substances as Schedule I controlled drugs, which makes them illegal to manufacture, sell, or possess without special federal authorization. The expiration date for this classification would move from March 31, 2025, to September 30, 2025. The extension gives Congress additional time to determine a permanent policy on these substances.
Drug enforcement agencies, courts, prosecutors, and anyone involved in manufacturing or distributing fentanyl analogues are directly affected. Researchers and medical professionals who study these substances must continue to obtain special federal permits, while patients using legally prescribed fentanyl-based medications are not affected.
Without the extension, the Schedule I classification would lapse, potentially limiting the government's ability to prosecute those who make, distribute, or possess fentanyl analogues illegally. The delay is a stopgap measure while Congress works toward a longer-term decision on how to regulate these substances permanently.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on the Judiciary.